These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8254207)

  • 1. Identification of two V beta 7-specific viral superantigens.
    Ignatowicz L; Kappler JW; Marrack P; Scherer MT
    J Immunol; 1994 Jan; 152(1):65-71. PubMed ID: 8254207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
    Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
    J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an endogenous mammary tumor virus involved in the clonal deletion of V beta 2 T cells.
    Jouvin-Marche E; Marche PN; Six A; Liebe-Gris C; Voegtle D; Cazenave PA
    Eur J Immunol; 1993 Nov; 23(11):2758-64. PubMed ID: 8223851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
    Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
    Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
    McMahon CW; Bogatzki LY; Pullen AM
    Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
    Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
    J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics.
    Pullen AM; Bogatzki LY
    J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
    Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
    J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transposon-mediated random insertions and site-directed mutagenesis prevent the trafficking of a mouse mammary tumor virus superantigen.
    McMahon CW; Traxler B; Grigg ME; Pullen AM
    Virology; 1998 Apr; 243(2):354-65. PubMed ID: 9568034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
    J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period.
    Niimi N; Wajjwalku W; Ando Y; Tomida S; Takeuchi M; Ueda M; Kaneda T; Yoshikai Y
    Eur J Immunol; 1994 Feb; 24(2):488-91. PubMed ID: 8299700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens.
    Jarvis CD; Germain RN; Hager GL; Damschroder M; Matis LA
    J Immunol; 1994 Feb; 152(3):1032-8. PubMed ID: 8301115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
    Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P
    J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule.
    Wirth S; Vessaz A; Krummenacher C; Baribaud F; Acha-Orbea H; Diggelmann H
    J Virol; 2002 Nov; 76(21):11172-5. PubMed ID: 12368363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Virology; 1996 Sep; 223(2):387-91. PubMed ID: 8806576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.